RE:YospralaHaven't had a chance to listen to the CC yet, but I'll try and get to it later tonight. Yeah, it's a shame more emphasis isn't put on the Canadian drug market of Tribute's business - everyone wants the big home run. But yeah, if they don't muck it up again, ARLZ should have both Bilastine and Yosprala coming online in the next 6 months. Who knows, maybe the 100M revenue projection for 2016 is actually accurate.
That sucking noise you've stared to hear, and will probably grow a lot louder, is the movement of money from Merus into Aralez as the premiere small-mid cap speciality pharma trading on the TMX. I'm sure we'll have to start enduring the bozo fund managers on BNN soon enough wreaking havoc with their short term glorified pump and dump tv spots. At least we can take Yosprala to stomach it all ha ha.
Happy to see TRX back into the 1.3x range. Green numbers make me happy.